Global Appetite Stimulant Market, By Types (Megestrol Acetate, Oxandrolone, Dronabinol, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Appetite Stimulant Market Analysis and Size
Even though it is not a new disease, an appetite disorder can be associated with modern lifestyle. Several manufacturers specifically promote their medications to increase appetite. Minerals, Vitamins, and herbs may also act as orexigenics, which can make lifestyle and dietary changes. The incidence of mental disorders that can cause anxiety and stress among the population and rise in the occurrence of eating disorders among women boost the market growth.
Data Bridge Market Research analyses that the appetite stimulant market is expected to reach USD 1.57 billion by 2030, which is USD 1 billion in 2022, and is expected to undergo a CAGR of 5.80% during the forecast period 2023 to 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Appetite Stimulant Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Types (Megestrol Acetate, Oxandrolone, Dronabinol, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Novartis AG (Switzerland), Sanofi (France), Pfizer Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Abbott (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Bausch Health Companies Inc. (Canada), AstraZeneca (U.K.), GSK plc (U.K.), Abbvie, Inc (U.S.), Apotex Inc (Canada), Lilly (U.S.)
|
|
Market Opportunities
|
|
Market Definition
An appetite stimulant or orexigenic is a drug, compound, or hormone which helps in improving appetite and may induce hyperphagia. The product could be a medicine or a naturally occurring neuropeptide hormone, such as neuropeptide orexin, or ghrelin which improves food consumption. Some vitamins and minerals, including zinc and vitamin B-1, can increase appetite. Though, these typically only work if the person has deficiencies in these nutrients.
Appetite Stimulant Market Dynamics
Drivers
- Rising Incidence of Appetite Disorders
The rising incidences of appetite disorders increase the growth of the market. Females are more susceptible to eating or appetite disorders compared to men. As per an article published in Psychology Today, about 0.5% to 3.7% of the female population suffers from anorexia nervosa while, an estimated 1.1% to 4.2% of the female population have bulimia nervosa in their lifetime. In the U.S., around 7 million women and 1 million men suffer from appetite disorders. Thus this boost the need for appetite stimulants
Opportunities
- Wide Availability of Appetite Stimulants
Certain vitamins and minerals, which includes zinc and vitamin B-1, can increase appetite. Zinc deficiency can cause typical symptoms such as loss of appetite and poor immune function. It may also cause changes in slow healing, taste perception, and hair loss. Taking zinc supplements may stimulate appetite in people having zinc deficiencies. Omega-3 fatty acids are the necessary healthy fats in the human diet. Some research advises that marine-based omega-3 fats may increase appetite and a person’s desire to eat. Also, fish oil and fatty fish such as salmon are the major sources of omega-3 fatty acids. Vegetarians and vegans are now drifting towards algae based omega-3 supplements. It has been seen that naturopathy may recommend bitter tasting herbs to people who want to improve their appetite or digestion.
Restraints/Challenges
- Late Approvals from Organizations
Numerous companies from different organizations cannot manufacture a drug unless a drug's patent stops. Thus, there are numerous chances that make the billion dollar drugs lose patents. This impedes the market growth.
This appetite stimulant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the appetite stimulant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Appetite Stimulant Market Scope
The appetite stimulant market is segmented on the basis of types, distribution channel, end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Types
- Megestrol Acetate
- Oxandrolone
- Dronabinol
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
End-User
- Hospitals
- Homecare
- Speciality Centres
- Others
Appetite Stimulant Market Regional Analysis/Insights
The appetite stimulant market is analyzed and market size insights and trends are provided by types, distribution channel, end users as referenced above.
The major countries covered in the appetite stimulant market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the market in the forecast period because of the presence of developed healthcare infrastructure within the region.
Asia-Pacific is considered to have the most lucrative period because of the increased awareness of the various appetite disorders.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Appetite Stimulant Market Share Analysis
The appetite stimulant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to appetite stimulant market.
Key players operating in the appetite stimulant market include:
- Novartis AG (Switzerland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Abbott (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bausch Health Companies Inc. (Canada)
- AstraZeneca (U.K.)
- GSK plc (U.K.)
- Abbvie, Inc (U.S.)
- Apotex Inc (Canada)
- Lilly (U.S.)
SKU-